Article

How AI in Clinical Trials Is Transforming Drug Development

Megha Kapadia — Fri, 10 Apr 2026 11:37:08 GMT

The early stages of drug development have benefited greatly from artificial intelligence. Target identification, molecule design, and lead optimization have all gotten faster. Yet clinical development, where most of the time and cost actually sit, remains slow. The work is scattered across sponsors, CROs, sites, and regulators. The AI capability is there, but the problem is the lack of integrated systems that connect the people and data that drive clinical decisions at scale. Three challenges explain why:

Axtria Ignite Global 2026: How AI Is Driving Enterprise Ownership

Admin — Wed, 25 Feb 2026 08:57:17 GMT

After a highly successful U.S. edition, Axtria Ignite Global arrived in India at a defining moment for the life sciences industry. The event took forward the conversation that AI is no longer about if AI will transform enterprises. It is about whether organizations are ready to move from experimentation to ownership.

From Data-Driven to Data-Governed: The AI Imperative

Admin — Fri, 17 Oct 2025 13:01:51 GMT

Over the past decade, life sciences companies have invested heavily in using data to drive better decisions, leveraging analytics to guide everything from clinical trial design to omnichannel engagement. However, new advancements in artificial intelligence keep changing what companies can do. In today’s AI-powered world, data alone is no longer the sole differentiator. It’s data + context. Organizations must evolve from being data-driven to being data-governed, and unlock real business value while staying compliant and competitive.

Data Fabric: The Key to Modern Data Architecture in Pharma AI

Admin — Thu, 16 Oct 2025 13:06:50 GMT

Pharmaceutical companies sit at a crossroad. On one side, there is an unprecedented opportunity with AI to unlock drug targets faster, predict patient outcomes more accurately, and create personalized engagement strategies that drive adherence. On the other hand, there is an unshakable reality that the data required to power these AI ambitions is fragmented. It is inconsistent and often trapped in silos within R&D, clinical, manufacturing, and commercial functions.

The uncomfortable truth: Many pharma AI projects stall not because of model sophistication, but because the enterprise cannot access, trust, and activate its own data at the speed and scale required.

Modernizing Pharma Data & Governance: Lessons from a Top Pharma Company

Megha Kapadia — Thu, 14 Aug 2025 09:56:03 GMT

Data has emerged as the foundation for competitive advantage and innovation in today's rapidly evolving healthcare ecosystem. For pharmaceutical companies, the modernization of data governance practices across commercial and R&D functions is no longer optional; it's essential.

Reimagining Field Force Excellence in Pharma with AI

Vineet Rathi — Tue, 12 Aug 2025 05:17:07 GMT

Introduction

As life sciences marketers and sales leaders navigate mounting pressure to boost productivity, enhance decision-making, and deliver measurable impact, artificial intelligence (AI) has emerged as a promising solution. While AI’s potential is widely acknowledged, its real-world effectiveness and business value remain under scrutiny. Navigating this evolving AI landscape requires cutting through the hype to uncover practical, data-driven opportunities.

Omnichannel Pharma Sales: Beyond NBA to Drive HCP Engagement

puneet.bhatia@axtria.com (Puneet Singh Bhatia) — Tue, 29 Jul 2025 11:20:23 GMT

Imagine a life sciences team that works with great precision. A sales rep predicts healthcare providers' (HCPs) needs before they express them. Medical science liaisons (MSLs) deliver cutting-edge insights powered by real-time data. A key account manager (KAM) navigates complex payer discussions with flawless agility. This isn't about the future; it's an urgent need in life sciences today. Field roles are evolving beyond their traditional functions.

Agentic AI in Pharma Forecasting | Axtria Ignite 2025 Insights

Admin — Wed, 23 Jul 2025 08:45:33 GMT

Pharmaceutical forecasting is a critical function that combines analytical rigor with strategic decision-making. To produce accurate and actionable forecasts, business teams in pharmaceutical companies must synthesize complex data, from clinical trial outcomes and market trends to competitive intelligence and patient behavior. However, traditional forecasting methods often involve manual data processing, time-consuming stakeholder reviews, and repetitive reporting tasks. These inefficiencies can delay insights and hinder responsiveness in a rapidly changing market.

Agentic AI for Epidemiological Forecasting in Pharma

Admin — Thu, 17 Jul 2025 12:23:57 GMT

Strategic forecasting is the foundation for data-driven decision-making in the life sciences. It allows pharmaceutical companies to predict the potential of pipeline assets by considering epidemiology, the competitive landscape, and patient drug adoption. This approach shapes critical strategies from clinical trial design to market access plans and promotional budgets by analyzing key healthcare metrics like disease prevalence, diagnosis rates, and therapy adoption.

Axtria Ignite 2025: Innovation and AI in Life Sciences

gope.biswas@axtria.com (Gope Biswas) — Wed, 25 Jun 2025 12:35:04 GMT

Axtria Ignite 2025, held June 4-5 at the Princeton Marriott at Forrestal, was a triumphant two-day summit that helped redefine the life sciences industry’s approach to win in a rapidly changing environment. Ignite 2025 gathered more than 400 senior executives from over 100 leading life sciences organizations to share expertise and learn from each other. This year’s theme focused on “Leadership in an Agentic Era.”